On the one hand, functional inhibition of PARP-1 antagonizes the aggregation of toxic Aβ oligomers; on the other hand, it partially suppresses AD-induced transposable element activation by epigenetically regulating chromatin structure and function. This evidence concerns the gene PARP1 and Alzheimer disease.